Through augmenting BDNF release, J11 effectively suppresses TLR4-mediated pro-inflammatory signaling, thereby attenuating the severity of NEC.74 Also in vitro study application of J11 to human intestinal resection specimens of NEC demonstrated a significant reduction in inflammation. The gene discussed is BDNF; the disease is necrotizing enterocolitis.